Browse by People

Milani, Mateus, Beckett, Alison J ORCID: 0000-0001-8377-325X, Al-Zebeeby, Aoula, Luo, Xu, Prior, Ian A ORCID: 0000-0002-4055-5161, Cohen, Gerald M and Varadarajan, Shankar ORCID: 0000-0002-8827-6567 (2019) DRP-1 functions independently of mitochondrial structural perturbations to facilitate BH3 mimetic-mediated apoptosis. Cell death discovery, 5 (1). p. 117.

Collapse authors list.
Carter, Rachel J, Milani, Mateus, Butterworth, Michael, Alotibi, Ahoud, Harper, Nicholas, Yedida, Govindaraju, Greaves, Georgia, Al-Zebeeby, Aoula, Jorgensen, Andrea L ORCID: 0000-0002-6977-9337, Schache, Andrew G ORCID: 0000-0001-9466-6038 et al (show 7 more authors) , Risk, Janet M ORCID: 0000-0002-8770-7783, Shaw, Richard J ORCID: 0000-0002-5157-4042, Jones, Terry M, Sacco, Joseph J, Hurlstone, Adam, Cohen, Gerald M and Varadarajan, Shankar ORCID: 0000-0002-8827-6567 (2019) Exploring the potential of BH3 mimetic therapy in squamous cell carcinoma of the head and neck. Cell Death and Disease, 10 (12). 912-.

Henz, Kristina, Al-Zebeeby, Aoula, Basoglu, Marion, Fulda, Simone, Cohen, Gerald M, Varadarajan, Shankar ORCID: 0000-0002-8827-6567 and Vogler, Meike (2019) Selective BH3-mimetics targeting BCL-2, BCL-X_L or MCL-1 induce severe mitochondrial perturbations. BIOLOGICAL CHEMISTRY, 400 (2). pp. 181-185.

Al-Zebeeby, Aoula, Vogler, Meike, Milani, Mateus, Richards, Caitlin, Alotibi, Ahoud, Greaves, Georgia, Dyer, Martin JS, Cohen, Gerald M and Varadarajan, Shankar ORCID: 0000-0002-8827-6567 (2019) Targeting Intermediary Metabolism Enhances The Efficacy Of BH3 Mimetic Therapy In Haematological Malignancies. Haematologica: the hematology journal, 104 (5). pp. 1016-1025.

Al-Zebeeby, Aoula, Vogler, Meike, Milani, Mateus, Richards, Caitlin, Alotibi, Ahoud, Greaves, Georgia, Dyer, Martin JS, Cohen, Gerald M and Varadarajan, Shankar ORCID: 0000-0002-8827-6567 (2018) Targeting intermediary metabolism enhances the efficacy of BH3 mimetic therapy in haematological malignancies. Haematologica: the hematology journal.